绿激光治疗前列腺增生症并发心力衰竭患者的临床疗效

Clinical efficacy of photoselective vaporization of prostate (Green Light PV) for benign prostatic hyperplasia with heart failure:a short-term prospective randomized trial

目的评价经尿道选择性绿激光汽化术治疗前列腺增生症并发心力衰竭患者的临床疗效。方法选择60例前列腺增生并发心衰患者随机分组,30例接受选择性绿激光前列腺汽化术(绿激光组),30例接受经尿道前列腺切除术(TURP组)。结果两组均取得良好疗效,但绿激光组在出血情况、膀胱灌洗液用量、拔管时间、住院时间等方面均优于TURP组。结论绿激光是治疗前列腺增生症并发心力衰竭的较好方法。

AIM： To evaluate the clinical efficacy of photoselective vaporization of the prostate （PVP） for the treatment of patient with benign prostatic hyperplasia （BPH） with heart failure. METHODS： A total of 60 BPH patients with heart failure were randomly allocated to PVP （ n = 30） or transurethral resection of the prostate （TURP, n = 30）. Perioperative parameters, functional outcome, and adverse events up to 1 month postoperatively were compared between groups. RESULTS： Although satisfactory effects were observed in both groups, patients who underwent PVP experienced less bleeding complications, less bladder irrigation solution, shorter time of catheterization, and shorter hospital stay. CONCLUSION： PVP is a safe and effective surgical approach for BPH patients with heart failure.